Capricor Therapeutics
CAPR
#8047
Rank
C$0.39 B
Marketcap
C$8.70
Share price
-4.36%
Change (1 day)
-60.25%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: C$0.39 Billion

As of February 2026 Capricor Therapeutics has a market cap of C$0.39 Billion. This makes Capricor Therapeutics the world's 8047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026C$0.39 B-0.12%
2025C$0.39 B-56.66%
2024C$0.91 B360%
2023C$0.19 B51.06%
2022C$0.13 B46.61%
2021C$90.17 M0.84%
2020C$89.42 M923.32%
2019C$8.73 M-50.15%
2018C$17.53 M-65.68%
2017C$51.07 M-33.23%
2016C$76.49 M10.37%
2015C$69.3 M36.04%
2014C$50.94 M26%
2013C$40.43 M1838.99%
2012C$2.08 M-90.53%
2011C$22.01 M2.57%
2010C$21.46 M-37.76%
2009C$34.48 M38.17%
2008C$24.95 M-81.12%
2007C$0.13 B3660.58%
2006C$3.51 M-38.46%
2005C$5.71 M-3.07%
2004C$5.89 M18.01%
2003C$4.99 M-70.08%
2002C$16.69 M

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Capricor Therapeutics was reported to be:

C$1.75 Billion
by Nasdaq info icon info icon
C$0.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$774.88 B 194,735.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$18.92 B 4,659.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$10.58 B 2,562.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$2.21 B 457.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
C$37.39 M-90.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$8.58 M-97.84%๐Ÿ‡บ๐Ÿ‡ธ USA